[Federal Register Volume 76, Number 21 (Tuesday, February 1, 2011)]
[Notices]
[Page 5592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2190]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH including adding, removing, or 
transferring the functions of such offices or establishing or 
terminating such offices; and (3) reorganize, divisions, centers, or 
other administrative units within an NIH national research institute or 
national center including adding, removing, or transferring the 
functions of such units, or establishing or terminating such units. The 
purpose of the Scientific Management Review Board (also referred to as 
SMRB or Board) is to advise appropriate HHS and NIH officials on the 
use of these organizational authorities and identify the reasons 
underlying the recommendations.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Scientific Management Review Board.
    Date: February 23, 2011.
    Time: 11:30 a.m. to 1:30 p.m.
    Agenda: Presentation and discussion will focus on NIH activities 
related to the Board's recommendations to create a new center for 
advancing translational medicine and therapeutics development. As 
requested by the Board in its Report on Translational Medicine and 
Therapeutics, NIH will provide an update on the proposed creation of 
a new center and its evaluation of the impact of such a center on 
other relevant extant programs at NIH, including the National Center 
for Research Resources. The Board will also discuss next steps 
regarding future SMRB activities. Time will be allotted on the 
agenda for public comment. To sign up for public comment, please 
submit your name and affiliation to the contact person listed below 
by February 22, 2011. Sign up will be restricted to one sign up per 
e-mail. In the event that time does not allow for all those 
interested to present oral comments, anyone may file written 
comments using the contact person address below.
    The toll-free number to participate in the teleconference is 1-
800-779-1545. Indicate to the conference operator that your 
Participant pass code is ``NIH'.
    Place: National Institutes of Health, Office of the Director, 
NIH, Office of Science Policy, 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, (Telephone Conference Call)
    Contact Person: Lyric Jorgenson, Office of Science Policy, 
Office of the Director, NIH, National Institutes of Health, 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, [email protected], 
(301) 496-6837.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The draft meeting agenda, meeting materials, dial-in 
information, and other information about the SMRB, will be available 
at http://smrb.od.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: January 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-2190 Filed 1-31-11; 8:45 am]
BILLING CODE 4140-01-P